Formula Grant 2001RINCAN

The National Aeronautics and Space Administration (NASA) awarded a $249,989.00 Project Grant to Northwest Research Associates, Inc. (Nwra) under the Science Mission Directorate (CFDA 43.001) on June 1, 2023. The funding will support Nwra's tasks for the Community Coordinated Modeling Center (CCMC) over a 2-year period through May 31, 2025. Nwra, a for-profit scientific research organization, will leverage its expertise in geophysical and space sciences to provide research, modeling, analysis,...

This $900,000 Project Grant was awarded by the National Science Foundation (NSF) under the Computer and Information Science and Engineering (CISE) Federal Grant Program (CFDA 47.070) to the University of California, San Diego (UCSD) on October 1, 2025. The CANIS project aims to develop a monitoring framework to safeguard the integrity of cybersecurity research workflows by curating and disseminating high-quality Internet Background Radiation (IBR) datasets for use with advanced machine...

The National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research Federal Grant Program (CFDA 93.394), awarded a $399,444 Project Grant to Cancure LLC (Canzx Biotherapeutics) on August 1, 2025. The funding will support a feasibility study of a novel agent that aims to stimulate NK (natural killer) and CD8 T cells for potential use in treating solid tumors. The study seeks to address challenges with persistence and sustained function of these cell-based therapies in the solid...

This federal Project Grant award, funded by the National Science Foundation's Geosciences program (CFDA 47.050), supports the annual CEDAR (Coupling, Energetics, and Dynamics of Atmospheric Regions) Workshop. The University Corporation for Atmospheric Research (UCAR), through its Cooperative Programs for the Advancement of Earth System Science (CPAESS), manages and facilitates this critical scientific event. With a total award of $598,605 over the project period from September 2025 to August...

This federal Project Grant award of $400,000 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports the advancement of next-generation CAR-T cell therapies for renal cell carcinoma (RCC). The award recipient, Cellinfinity Bio Inc., is developing novel CAR-T cell modifications, including a PRDM1 exon 3 knockout and a CTLA-4 cytoplasmic tail fusion, to enhance CAR-T cell efficacy against RCC tumors. The project aims to evaluate the combination of these...

The National Cancer Institute (NCI), under the federal Cancer Biology Research grant program (CFDA 93.396), awarded a $218,089 Project Grant to the University of California, Santa Barbara (UCSB) to develop and evaluate a novel chimeric antigen receptor macrophage (CAR-M) immunotherapy for the treatment of triple-negative breast cancer (TNBC). The project, titled "RAC-Enhanced Chimeric Antigen Receptor-Macrophage (RACE-CAR-M) Immunotherapy for Triple Negative Breast Cancer," aims to...

This Project Grant award of $2,840,768 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) aims to enhance the therapeutic efficacy and minimize side effects of the chemotherapy drugs cyclophosphamide (CPA) and doxorubicin (DOX) in treating triple-negative breast cancer (TNBC). The key objectives are to improve the metabolic activation of CPA and mitigate the cardiotoxicity of DOX by leveraging dual activation of the human constitutive androstane receptor (HCAR) and...

This $575,051 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support the University of Arizona Cancer Center (UACC) in enhancing its NCI-funded clinical research enterprise over a 5-year period from September 1, 2025 to August 31, 2030. The key objectives are to grow the breadth of the UACC's clinical trial portfolio to better serve its diverse patient population, increase accruals to interventional treatment trials (especially NCI-sponsored...

This federal Project Grant award, totaling $696,140, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The grant aims to test a digital psychoeducation-activation tool and implementation strategy, called ICAN DEPCARE, to improve uptake of evidence-based depression treatment among cancer patients. The project, led by The Trustees of Columbia University in the City of New York, will conduct a clinic-level cluster randomized...

This $286,479 Project Grant awarded by the National Aeronautics and Space Administration (NASA) Science Mission Directorate (CFDA 43.001) supports Texas A&M University-Corpus Christi (TAMU-CC) in executing a balanced science program. The award enables TAMU-CC, a Hispanic-Serving Institution, to participate as a key partner and enabler in the agency's priorities and congressional direction through its Division of Research & Innovation. The funding will facilitate sophisticated...